Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPα in human umbilical vein endothelial cells from gestational diabetes

被引:41
作者
Farias, Marcelo [1 ,2 ]
Puebla, Carlos [1 ,2 ]
Westermeier, Francisco [1 ,2 ]
Jo, Miguel J. [1 ,2 ]
Pastor-Anglada, Marcal [3 ,4 ]
Casanello, Paola [1 ,2 ]
Sobrevia, Luis [1 ,2 ]
机构
[1] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Dept Obstet & Gynaecol,CMPL, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Dept Obstet & Gynaecol,PRL,Med Res Ctr, Santiago, Chile
[3] Univ Barcelona, Dept Biochem & Mol Biol, Inst Biomed, Barcelona, Spain
[4] CIBER EHD, Barcelona, Spain
关键词
Adenosine; Diabetes; Endothelium; Transcription factor; CHOP; ENDOPLASMIC-RETICULUM STRESS; KAPPA-B; EXPRESSION; MELLITUS; GENE; CHOP; HYPERGLYCEMIA; MACROPHAGES; DYSFUNCTION; APOPTOSIS;
D O I
10.1093/cvr/cvp410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reduced expression of human equilibrative nucleoside transporter 1 (hENT1) results from nitric oxide (NO)-dependent reduced SLC29A1 transcriptional activity in human umbilical vein endothelial cells (HUVECs) from gestational diabetes. As expression of the transcription factor C/EBP homologous protein 10 (hCHOP, which forms heterodimers with C/EBP alpha transcription factor) is activated by NO and induced in diabetes mellitus, we hypothesize that hCHOP plays a role in the gestational diabetes-reduced hENT1 expression in HUVECs. HUVEC primary cultures from 42 normal and 42 gestational diabetic pregnancies were used for adenosine uptake assays. Real-time PCR (mRNA quantification), western blotting (protein abundance), and luciferase activity (SLC29A1 promoter activity) were used. hCHOP-C/EBP alpha activity was assayed by chromatin immunoprecipitation. Overlap extension mutagenesis was used to generate a mutated hCHOP-C/EBP alpha consensus site at the SLC29A1 promoter, and endothelial NO synthase (eNOS) siRNA recombinant adenovirus was used to knock down eNOS. hCHOP nuclear protein abundance and binding to DNA were higher in gestational diabetes, paralleled by reduced SLC29A1 promoter activity, hENT1 expression, and transport activity. These changes were blocked by hCHOP consensus sequence mutation (-1845G > T and -1844C > A), eNOS-siRNA-induced knockdown, and N-G-nitro-l-arginine methyl ester (NOS inhibitor), and were mimicked by S-nitroso-N-acetyl-l, d-penicillamine (NO donor) in cells from normal pregnancies. hCHOP and C/EBP alpha overexpression mimicked gestational diabetes effects in cells from normal pregnancies, but did not alter SLC29A1 promoter activity or hENT1-adenosine transport in cells from gestational diabetes. The hCHOP-C/EBP alpha complex down-regulates SLC29A1 expression in an NO-dependent manner in HUVECs from gestational diabetes.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 42 条
  • [1] Characterization and functional analysis of the promoter for the human equilibrative nucleoside transporter gene, hENT1
    Abdulla, Parween
    Coe, Imogen R.
    [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2007, 26 (01) : 99 - 110
  • [2] The equilibrative nucleoside transporter family, SLC29
    Baldwin, SA
    Beal, PR
    Yao, SYM
    King, AE
    Cass, CE
    Young, JD
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05): : 735 - 743
  • [3] Nitric oxide and the regulation of gene expression
    Bogdan, C
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (02) : 66 - 75
  • [4] Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium
    Casanello, P
    Torres, A
    Sanhueza, F
    González, M
    Farías, M
    Gallardo, V
    Pastor-Anglada, M
    San Martín, R
    Sobrevia, L
    [J]. CIRCULATION RESEARCH, 2005, 97 (01) : 16 - 24
  • [5] Reduced L-Arginine Transport and Nitric Oxide Synthesis in Human Umbilical Vein Endothelial Cells from Intrauterine Growth Restriction Pregnancies is Not Further Altered by Hypoxia
    Casanello, P.
    Krause, B.
    Torres, E.
    Gallardo, V.
    Gonzalez, M.
    Prieto, C.
    Escudero, C.
    Farias, M.
    Sobrevia, L.
    [J]. PLACENTA, 2009, 30 (07) : 625 - 633
  • [6] Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: Implications in foetal endothelial dysfunction in human pregnancy diseases
    Casanello, Paola
    Escudero, Carlos
    Sobrevia, Luis
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2007, 5 (01) : 69 - 84
  • [7] Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort - Kaiser permanente of Colorado GDM screening program
    Dabelea, D
    Snell-Bergeon, JK
    Hartsfield, CL
    Bischoff, KJ
    Hamman, RF
    McDuffie, RS
    [J]. DIABETES CARE, 2005, 28 (03) : 579 - 584
  • [8] delaTorre A, 1999, J IMMUNOL, V162, P4101
  • [9] The role for endoplasmic reticulum stress in diabetes mellitus
    Eizirik, Decio L.
    Cardozo, Alessandra K.
    Cnop, Miriam
    [J]. ENDOCRINE REVIEWS, 2008, 29 (01) : 42 - 61
  • [10] HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
    Eltzschig, HK
    Abdulla, P
    Hoffman, E
    Hamilton, KE
    Daniels, D
    Schönfeld, C
    Löffler, M
    Reyes, G
    Duszenko, M
    Karhausen, J
    Robinson, A
    Westerman, KA
    Coe, IR
    Colgan, SP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (11) : 1493 - 1505